Gilead Sciences, Inc. makes Descovy®, a daily pill for PrEP (Pre-exposure Prophylaxis). Also known as Gilead, the company is based in Foster City, California.
How Can I Contact Gilead Sciences?
If you have general questions about the company, you can call corporate headquarters at 1-800-GILEAD-5. For questions about medical information, call 1-866-MEDI-GSI. Customer support representatives are available between Monday and Friday, from 6 a.m. to 4 p.m. PST. If you prefer to contact Gilead Sciences online, you can use the company’s medical information request form.
Who Runs Gilead Sciences?
Gilead Sciences has a 10-member board of directors and a nine-member senior management team. Its senior management team includes:
- Andrew Dickinson: Executive Vice President of Corporate Development and Strategy since 2016
- William A. Lee: Executive Vice President of Research since 2015
- Jyoti Mehra: Executive Vice President of Human Resources since 2017
- Johanna Mercier: Chief Commercial Officer (CCO) since 2019
- Daniel O’Day: Chief Executive Officer (CEO) since 2019
- Brett A. Pletcher: Executive Vice President and General Counsel
- Christi Shaw: CEO of Kite business unit
- Robin L. Washington: Executive Vice President since 2014 and Chief Financial Officer (CFO) since 2008
- Taiyin Yang: Executive Vice President of Pharmaceutical Development and Manufacturing since 2015
The company’s board of directors includes:
- Jacqueline K. Barton: Professor at California Institute of Technology
- John F. Cogan: Lead Independent Director of Gilead Sciences
- Kelly A. Kramer: Executive Vice President and CFO of Cisco Systems
- Kevin E. Lofton: CEO of CommonSpirit Health
- Harish Manwani: Retired COO of Unilever
- Daniel O’Day: CEO of Gilead Sciences
- George P. Shultz: Director Emeritus of Gilead Sciences
- Richard J. Whitley: Professor of Pediatrics, Microbiology, Medicine, and Neurosurgery at the University of Alabama, Birmingham
- Gayle E. Wilson: Chairman Emeritus of the California State Summer School for Math and Science
- Per Wold-Olsen: Retired President of the Human Health Intercontinental Division at Merck & Co.
What Medications Does Gilead Make?
Gilead makes dozens of medications that treat cardiovascular issues, hematology and oncology conditions, HIV and AIDS, liver diseases and other issues. The company develops medications primarily for the United States market:
- Cardiovascular: Letairis®, Lexiscan®, Ranexa®
- Hematology and Oncology: Yescarta®, Zydelig®
- HIV and AIDS: Atripia®, Biktarvy®, Complera®, Descovy®, Emtriva®, Genvoya®, Odefsey®, Stribild®, Truvada®, Tybost®, Viread®
- Inflammation and Respiratory: Cayston®, Tamiflu®
- Liver Diseases: Epclusa®, Harvoni®, Hepsera®, Sovaldi®, Vemlidy®, Viread®, Vosevi®
What Is Gilead Science’s Mission?
Gilead Sciences strives to develop cutting-edge medications that address neglected patient needs. For more than 30 years, the company has researched and commercialized medications that treat serious diseases around the globe. To advance its mission, Gilead Sciences prioritizes five core values: integrity, inclusion, teamwork, accountability, and excellence. The company focuses on providing physicians with optimal resources, working closely with patients and advocates and encouraging teamwork and commitment.
How Does Gilead Advance Global Health?
In addition to developing much-needed medications for life-threatening conditions around the world, Gilead Sciences also contributes to public health programs. The company focuses on programs that educate patients, offer support to vulnerable populations, encourage disease prevention, and improve health care infrastructure. Some of the company’s most prominent global health projects include:
- Partnering with the President’s Emergency Plan for AIDS Relief (PEPFAR) to decrease HIV infections in teen girls and children in sub-Saharan Africa
- Striving to eliminate viral hepatitis via awareness, screening, and treatment programs around the world
- Collaborating with non-governmental organizations (NGOs) and public health organizations to eliminate the thread of ebola across the globe
- Working with the World Health Organization (WHO) to provide visceral leishmaniasis (VL) treatments at no cost
How Does Gilead Partner With Its Community?
To work toward its mission, Gilead Sciences partners with organizations and communities around the world. These international international include education, patient care, and prevention strategies.
In 2017, Gilead dedicated $100 million to funding its COMmitment to Partnership in Addressing HIV/Aids in Southern States (COMPASS) Initiative. This decade-long program focuses on working with community organizations to address the spread of HIV/AIDS in the Southern U.S. The COMPASS Initiative takes a holistic approach to the issue by making medical care more accessible and improving local advocacy.
Gilead Lift focuses on improving cell therapy education, awareness, and experience. This initiative funds programs that increase outreach and improve access to this innovative cancer treatment.
Gilead HIV Age Positively
This initiative provides assistance to programs that help patients with HIV live better lives as they age via better care, improved resources and increased education. The Gilead HIV Age Positively initiative supports a total of 30 programs with $17.6 million in funding.
The Gilead TRANScend Community Impact Fund is designed to assist the transgender community, which is significantly impacted by the spread of HIV. This initiative provides support to organizations striving to build better, healthier, and safer communities for transgender people. It funds program development and community services that focus on decreasing the effect of HIV on transgender patients.
This five-year program is designed to reduce the impact of the hepatitis epidemic in greater Appalachia. HepConnect offers expanded screening, provides community education, and improves health care infrastructure in Indiana, Kentucky, North Carolina, Tennessee, and West Virginia.
How Does Gilead Sciences Give Back?
Gilead also has a comprehensive giving program. Through its grants and awards, the company strives to improve access to life-saving medications, eliminate common barriers to health care and improve medical knowledge around the world.
Gilead provides financial support for a wide variety of health care education and advocacy programs based in the U.S. and Canada. The company funds initiatives that address its focus areas: hematology and oncology, HIV/AIDS, inflammatory and respiratory conditions, and liver diseases.
Since 2005, the Gilead Foundation has supported programs designed to better the health of underserved communities in nations around the world. This nonprofit organization provides financial assistance to programs that address hepatitis and HIV education, outreach, and prevention.
Gilead Public Health Award
To support scientific research, Gilead Sciences also offers the Gilead Public Health Award (GHPA) to junior faculty members and post-doctoral students working at academic and research institutions in select countries. The company presents this award to researchers who focus on managing, treating, preventing, and educating patients about viral hepatitis in low- and middle-income nations.